CharlesMalcolmClarkJr.MD

PubMed

• 36 citations
  Clinical, metabolic and psychological outcomes and treatment costs of a prospective randomized trial based on different educational strategies to improve diabetes care...
  Juan José Gagliardino, Silvia Gorbán de Lapertosa, G. Pfirter, M. Villagra, Joaquín E. Caporale, Claudio Gonzalez, Jorge Federico Elgart, Lorena Gonzalez, C. Cernadas,...> ;Diabetic Medicine. 2013 Sep 1
• 8 citations
  Peer support in diabetes management -- toward global application. Overview.
  Charles M. Clark> ;Family Practice. 2010 Jun 1
• 15 citations
  Comparison of clinical-metabolic monitoring and outcomes and coronary risk status in people with type 2 diabetes from Australia, France and Latin America.
  Juan José Gagliardino, Line Kleinebreil, Stephen Colagiuri, Jeff R. Flack, Joaquín Caporale, Fernando Siri, Charles M. Clark> ;Diabetes Research and Clinical Practice. 2010 Apr 1
• Glycemic control and hypoglycemia: is the loser the winner? Response to Perlmuter et al.
  Charles M. Clark> ;Diabetes Care. 2009 Mar 1
• 19 citations
  Diabetes and heart disease an evidence-driven guide to risk factors management in diabetes.
  Amale Lteif, Kieren J. Mather, Charles M. Clark> ;Cardiology in Review. 2003 Sep 1
• 5 citations
  Incorporating the results of diabetes research into clinical practice: celebrating 25 years of diabetes research and training center translation research.
  Charles M. Clark, Marshall H. Chin, Stephen N. Davis, Edwin B. Fisher, Roland G. Hiss, David G. Marrero, Elizabeth A. Walker, Judith Wylie-Rosett> ;Diabetes Care. 2001 Dec 1
• Cost-effectiveness analyses.
  Charles M. Clark> ;Annals of Internal Medicine. 2001 Sep 4
• 75 citations
  A Systematic Approach to Risk Stratification and Intervention Within a Managed Care Environment Improves Diabetes Outcomes and Patient Satisfaction
  Charles M. Clark, James Snyder, Robert L. Meek, Linda M. Stutz, Christopher G. Parkin> ;Diabetes Care. 2001 Jun 1
• 329 citations
  Basal Insulin Therapy in Type 2 Diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin
  Julio Rosenstock, Sherwyn Schwartz, Charles M. Clark, Glen Park, David Donley, Mike B. Edwards> ;Diabetes Care. 2001 Apr 1
• 32 citations
  The National Diabetes Education Program, Changing the Way Diabetes Is Treated Comprehensive diabetes care
  Charles M. Clark, Judith E. Fradkin, Roland G. Hiss, Frank Vinicor, Elizabeth Warren-Boulton, Rodney A. Lorenz> ;Diabetes Care. 2001 Apr 1
• 10 citations
  Using hospitalization rates to track the economic costs and benefits of improved diabetes care in the Americas: a proposal for health policy makers.
  Juan José Gagliardino, Rhys Williams, Charles M. Clark> ;Diabetes Care. 2000 Dec 1
• 59 citations
  Promoting early diagnosis and treatment of type 2 diabetes: the National Diabetes Education Program.
  Charles M. Clark, Judith E. Fradkin, Roland G. Hiss, Frank Vinicor, Elizabeth Warren-Boulton, Rodney A. Lorenz> ;JAMA. 2000 Jul 19
• 3 citations
  Combating Sloth as Well as Gluttony: The Role of Physical Fitness in Mortality among Men with Type 2 Diabetes
  Charles M. Clark> ;Annals of Internal Medicine. 2000 Apr 18
• 36 citations
  Reducing the burden of diabetes: managing cardiovascular disease.
  Harry Keen, Charles M. Clark, Markku Laakso> ;Diabetes/metabolism Research and Reviews. 1999 May 1
• 9 citations
  The National Diabetes Education Program: changing the way diabetes is treated.
  Charles M. Clark> ;Annals of Internal Medicine. 1999 Feb 16
• 28 citations
  Screening and treatment of diabetic nephropathy by primary care physicians.
  Stephanie Kakos Kraft, Emmanuel N. Lazaridis, Chunfu Qiu, Charles M. Clark, David G. Marrero> ;Journal of General Internal Medicine. 1999 Feb 1
• 14 citations
  The Burden of Chronic Hyperglycemia
  Charles M. Clark> ;Diabetes Care. 1998 Dec 1
• 9 citations
  Reducing the burden of diabetes. The National Diabetes Education Program.
  Charles M. Clark> ;Diabetes Care. 1998 Dec 1
• 36 citations
  How Should We Respond to the Worldwide Diabetes Epidemic
  Charles M. Clark> ;Diabetes Care. 1998 Apr 1
• 1 citations
  Clinical trials with glimepiride.
  Charles M. Clark, Ahdy W. Helmy> ;Drugs of Today. 1998 Jan 1
• 82 citations
  Gestational Diabetes: Should It Be Added to the Syndrome of Insulin Resistance?
  Charles M. Clark, Chunfu Qiu, Barbara Amerman, Beverly Porter, Naomi S. Fineberg, Saleh Aldasouqi, Alan M. Golichowski> ;Diabetes Care. 1997 May 1
• 43 citations
  Primary care physicians' practice patterns and diabetic retinopathy. Current levels of care.
  Stephanie Kakos Kraft, David G. Marrero, Emmanuel N. Lazaridis, Naomi S. Fineberg, Chunfu Qiu, Charles M. Clark> ;Archives of Family Medicine. 1997 Jan 1
• 9 citations
  Forum Two: Unanswered Research Questions about Metabolic Control in Non-Insulin-dependent Diabetes Mellitus
  John A. Colwell, Charles M. Clark> ;Annals of Internal Medicine. 1996 Jan 1
• 8 citations
  Patterns of referral and examination for retinopathy in pregnant women with diabetes by primary care physicians.
  David G. Marrero, Patricia S. Moore, Carl D. Langefeld, Charles M. Clark> ;Ophthalmic Epidemiology. 1995 Jun 1
• 6 citations
  The Potential Role of Diabetes Guidelines in the Reduction of Medical Injury and Malpractice Claims Involving Diabetes
  Charles M. Clark, Eleanor D. Kinney> ;Diabetes Care. 1994 Feb 1
• Join now to see all

Journal Articles

• Type 2 diabetes patients educated by other patients perform at least as well as patients trained by professionals.  
  Gagliardino JJ, Arrechea V, Assad D, Gagliardino GG, Gonzalez S, Lucero S, Rizzuti L, Zufriategui Z, Clark CM Jr, Diabetes/Metabolism Research and Reviews, 2/1/2013
• Effectiveness of Staged Diabetes Management on the Quality of Diabetes Care in Mexico.  
  Rodriguez-Saldana J, Morales de Teresa MA, Rosales-Campos AC, Clark Jr. CM, Mazze RS, Strock E, Practical Diabetes International, 7/1/2010
• Comparison of clinical-metabolic monitoring and outcomes and coronary risk status in people with type 2 diabetes from Australia, France and Latin America.  
  Gagliardino JJ, Kleinebreil L, Colagiuri S, Flack J, Caporale JE, Siri F, Clark CM Jr, Diabetes Research and Clinical Practice, 3/1/2010
• Predictors of perceived risk of the development of diabetes.  
  Gallivan J, Brown C, Greenberg R, Clark C, Diabetes Spectrum, 1/1/2009
• A patient-centered treatment program for type 2 diabetes and associated cardiovascular risk factors in the city of Corrientes, Argentina. Study design and baseline data.  
  Gagliardino JJ, Lapertosa S, Villagra M, Caporale JE, Oliver P, Gonzalez C, Siri F, Clark C , on behalf of the PRODIACOR participating members, Contemporary Clinical Trials, 7/1/2007
• Development and Implementation of Advanced Training Course for Diabetes Educators in Argentina.  
  Gagliardino JJ, del Carmen Malbran M, Clark CM, Diabetes Spectrum, 1/1/2007
• Prevention and early identification of type 2 diabetes in adults: An update from the National Diabetes Education Program.  
  Clark CM, Gavin JR, Blonde L, Warren-Boulton E, Behavioral Health Trends, 12/1/2006
• Prevention and Early Identification of Type 2 Diabetes in Adults: an Update. From the National Diabetes Education Program.  
  Clark CM, Gavin JR, Blonde L, Warren-Boulton E, Diabetes Trends, 10/1/2005
• Prevention and early identification of type 2 diabetes in adults: an update from the National Diabetes Education Program.  
  Clark CM, Gavin JR III, Blonde L, Warren-Boulton E, Drug Benefit Trends, 10/1/2005
• Staged Diabetes Management in Mexico: optimizing care with limited resources.  
  Rodriguez-Saldana J, Jonguitud-Falcon A, Clark CM, Escorza-Dominguez AB, Morales de Teresa M, Ortiz-Gress AA, Diabetes Voice, 12/1/2003
• Diabetes and Heart Disease: An Evidence-Driven Guide to Risk Factors Management in Diabetes.  
  Amale A, Lteif MD, Kieren J, Mather MD, Charles M, Clark MD, Cardiology in Review, 9/1/2003
• A systematic approach to risk stratification and intervention within a managed care environment improves diabetes outcomes and patient satisfaction.  
  Clark CM, Snyder JW, Meek RL, Stutz LM, Parkin CG, Diabetes Care, 6/1/2001
• Incorporating the results of diabetes research into clinical practice: celebrating 25 years of diabetes research and training center translation research.  
  Clark CM, Chin MH, Davis SN, Fisher E, Hiss RG, Marrero DG, Walker EA, Wylie-Rosett J, Diabetes Care, 1/1/2001
• Basal Insulin Therapy in Type 2 Diabetes. 28-week comparison of insulin glargine (HOE 901) and NPH insulin.  
  Rosenstock J, Schwartz SL, Clark CM, Park GD, Donley DW, Edwards MB, Diabetes Care, 1/1/2001
• Prevention of the Microvascular Complications in Type 2 Diabetes.  
  Clark CM, Diabetes Trends, 1/1/2000
• Promoting early diagnosis and treatment of type 2 diabetes: the National Diabetes Education Program.  
  Clark CM, Fradkin JE, Hiss RG, Lorenz RA, Vinicor F, Warren-Boulton E, JAMA, 1/1/2000
• What We Can Learn From Argentina.  
  Clark CM, Diabetes Care, 1/1/2000
• Using Hospitalization Rates to Track the Economic Costs and Benefits of Improved Diabetes Care in the Americas. A proposal for health policy makers.  
  Gagliardino JJ, Williams R, Clark CM, Diabetes Care, 1/1/2000
• The National Diabetes Education Program: Changing the Way Diabetes is Treated.  
  Clark CM, Annuals of Internal Medicine, 1/1/1999
• Diabetes Clinic commentary (editorial).  
  Clark CM, Cardiology Review, 1/1/1999
• Reducing the Burden of Diabetes: Managing Cardiovascular Disease.  
  Keen H, Clark CM, Laakso M, Diabetes/Metabolism Research and Reviews, 1/1/1999
• Type 2 diabetes and macrovascular disease: Epidemiology and etiology.  
  Clark CM, Perry RC, Am Heart J, 1/1/1999
• Combating Sloth as Well as Gluttony: The Role of Physical Fitness in Mortality among men with Type 2 Diabetes.  
  Clark CM, Annuals of Internal Medicine, 1/1/1999
• Preventing diabetes complications: Living up to the promise.  
  Clark CM, Nutrition, 1/1/1998
• Emerging treatments for diabetes mellitus.  
  Clark CM, On The Cutting Edge, 1/1/1998
• Join now to see all

Books/Book Chapters

• Family Practice 
  Chapter: Overview 
  Page 3 - 5Clark CM Jr2010
• The DOTA Education Task Group Standards and Norms for Diabetes Education Programs For People with Diabetes in the Americas. 
  Clark CM Jr2000
• American Diabetes Association: Physician’s Guide to Insulin-Dependent (Type n Diabetes. Diagnosis and Treatment 
  Clark CM Jr1988
• American Diabetes Association: The Physician’s Guide to Type 11 Diabetes (NIDDM). Diagnosis and Treatment, 
  Clark CM Jr1984
• National Diabetes Advisory Board: The Prevention and Treatment of Five Complications of Diabetes: A Guide for Primary Care Practitioners. 
  Clark CM JrUS Department of Health & Human Services1983
• Biochemical Development of the Fetus and Neonat 
  Chapter: The growth and metabolism of the developing rat heart. 
  Page 185 - 212Clark J, Clark CMEditors: Colin T. Jones.Elsevier Biomedical Press1982
• Early Diabetes in Early Life 
  Chapter: Development of hormone receptors in the isolated fetal rat heart. 
  Page 105 - 114Vinicor F, Clark J, Clark CM JrEditors: Rafael A, Camerine-Davalors.Academic Press1975
• Clinical Aspects of Metabolic Bone Disease 
  Chapter: Derivation and significance of urinary cyclic AMP in man. 
  Page 67 - 73Bell NH, Frideman HR, Clark CM Jr., Allen DOEditors: Frame B, Parfitt AM, Duncan H.Excerpta Medica, Amsterdam1973
• Join now to see all

Abstracts/Posters

• Early Termination of the Diabetes Control and Complications Trial.
  Lachin JM, Cleary, P, Crofford O, Genuth S, Nathan D, Clark C, Ferris F, Siebert C, for the DCCT Research Group, Data Monitoring in Clinical Trials, 1/1/2006
• An Educational Approach to Diabetes Mellitus in Digestive (CADIEQ) International Diabetes Federation
  Clark CM Jr, The CADIEQ Committee, Mexico City NDC, 1/1/2000
• The United States of America’s National Diabetes Education Program (NDEP).
  Clark CM and the NDEP Steering Committee, Diabetologia, 1/1/1997
• A new approach to continuing medical education: Impact on physician behavior and patient outcomes.
  Moore P, Marrero D, Langefeld C, Clark CM, Diabetes, 1/1/1991
• Do community physicians adhere to ADA treatment guidelines?
  Marrero D, Moore P, Fineberg N, Moorman N, Clark C, Wilson M, Diabetes, 1/1/1989
• The results of the long-term open-label administration of Alredase (Tolrestat) in the treatment of diabetic neuropathy.
  Koglin L, Clark C, Ryder S, Mullane JF, Diabeta, 1/1/1985
• A controlled clinical trial of the effects of patient and physician education on diabetic patient outcomes.
  Vinicor F, Cohen S, Mazzuca S, Clark CM, Diabeta, 1/1/1983
• Persistence of effects of physician education on diabetes care practices.
  Mazzuca SM, Clark CM, Diabeta, 1/1/1983
• Evaluating diabetes instruction for physicians by changes in practice.
  Mazzuca SM, Clark CM Jr, Diabeta, 1/1/1982
• Characterization and significance of hepatic receptors for insulin during fetal and neonatal life.
  Vinicor F, Clark CM Jr, Diabeta, 1/1/1980
• Multiple factors found associated with abnormal nerve conduction velocity (NCV) in adult diabetics.
  Kuebler TW, Markand ON, Norton JA Jr, ., Fineberg SE, Vinicor F, Clark CM Jr, Clin Res, 1/1/1980
• An analysis of the costs and benefits of a vaccination and screening program to prevent insulin-dependent diabetes mellitus.
  England WL and Roberts SD (Spon: C M Clark, Jr.), Clin Res, 1/1/1980
• Evidence for modulation of adenylate cyclase by guanyl nucleotides (GN) in the developing rat heart.
  Clark JB, Vinicor F, Clark CM Jr, Clin Res, 10/1/1977
• Rat heart adenylyl cyclase activity during postnatal development: Effects of glucagon and 5’-guanylylimidodiphosphate.
  Yount EA, Clark CM Jr., (Spon: Julia F. Clark), Federation Proceedings, 3/1/1976
• Effects of guanosine triphophate (GTP) on the ontogenesis of rat cardiac adenylate cyclase
  Vinicor F, Wills S, Clark CM Jr, Clin Res, 1/1/1976
• Evidence that cyclic AMP does not mediate the inotropic and chronotropic effects of glucagon in the fetal mouse heart.
  Clark CM Jr., Allen DO, Wakeland JR, Wildenthal K, Clin Res, 1/1/1975
• Development of glucagon sensitivity in neonatal rat liver.
  Vinicor F, Higdon G, Clark JF, Clark CM Jr, Diabetes, 1/1/1975
• Suitability of isolated rat heart cells for studies on the mechanism of hormone action.
  Clark JF, Clark CM Jr., Vinicor F, Diabetes, 1/1/1975
• Spontaneous development of a glucagon-sensitive adenylate cyclase system in cultured
  Vinicor F, Kohalmi D, Clark CM Jr., Clin Res, 1/1/1975
• Insulin binding to heart cells isolated from adult and newborn rats.
  Clark JF, Clark CM Jr, Clin Res, 1/1/1975
• Studies on species in the development of myocardial hormone receptors in tissue
  Vinicor F, Kohalmi D, Clark CM Jr, Clin Res, 1/1/1974
• Studies on the mechanism of action of glucagon in the adult mouse heart.
  Vinicor F,Waller D, Kohalmi D, Clark CM Jr, Allen DO, Yount E, Levey G, Wildenthal K, Clin Res, 1/1/1974
• Biological activity of monolodinated glucagon in rat liver.
  Vinicor F, Fricke R, Clark CM Jr, Clin Res, 1/1/1974
• Glucose tolerance in identical twins and their offspring.
  Bader PE, Bingle GJ, Uy PL, Clark CM Jr, Nance W, Clin Res, 1/1/1973
• Characterization of glucose metabolism in the isolated rat heart during fetal and neonatal development.
  Clark CM Jr, Excerpta Medica, 1/1/1973
• Join now to see all

Lectures

• Glimepiride: dose-regimen and dose-response studies 
  Leadership Forum: Type II Diabetes. Roundtable Proceedings. - 1/1/1996
• Characterization and significance of hepatic receptors for insulin during fetal and neonatal life. 
  Presented at 40th Annual Meeting, American Diabetes Association, Washington, DC - 6/1/1980
• Physicians’ beliefs as predictors of their clinical intentions. 
  Annual Meeting of the American Education Research Association, Boston, MA - 1/1/1980
• Characterization of glucose metabolism in the isolated rat heart during fetal and neonatal development. 
  Congress of the International Diabetes Federation, Brussels, Belgium - 7/1/1973
• Join now to see all

Other

• Effective Diabetes Management in a Primary Care Setting. 
  Clark CM Jr
  CD-ROM Indiana University School of Medicine Division of Continuing Medical Education - 1/1/2000